Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Sales hopes for new Novartis, Merck heart drugs under microscope

      Sales hopes for new Novartis, Merck heart drugs under microscope

      Ruby Khatun Khatun30 Jun 2017 9:42 AM IST
      London: Novartis and Merck have both surprised experts in the past week by finding new ways to tackle heart disease, although the jury remains out as...
      Philips buys US cardiac-implant firm for 1.9 billion euros

      Philips buys US cardiac-implant firm for 1.9 billion euros

      Ruby Khatun Khatun29 Jun 2017 4:02 PM IST
      The Hague: Dutch electronics giant Philips announced it was buying for 1.9 billion euros ($2.2 billion) a specialist US company manufacturing...
      USFDA gives nod to Zydus Cadila

      USFDA gives nod to Zydus Cadila's overactive bladder tablets

      Ruby Khatun Khatun29 Jun 2017 4:00 PM IST
      New Delhi: The US Food and Drug Administration (USFDA) has given final approval to drug firm Zydus Cadila to market oxybutynin chloride tablets used...
      Unichem Laboratories to focus on expansion of product portfolio

      Unichem Laboratories to focus on expansion of product portfolio

      Ruby Khatun Khatun29 Jun 2017 3:58 PM IST
      Mumbai: Unichem Laboratories said it will continue to focus on expansion of the product portfolio and increasing market penetration in both domestic...
      Columbia Asia to invest Rs 400 Crore on 2 new hospitals in India

      Columbia Asia to invest Rs 400 Crore on 2 new hospitals in India

      Ruby Khatun Khatun29 Jun 2017 3:53 PM IST
      New Delhi: International healthcare firm Columbia Asia will invest over Rs 400 crore to set up two new hospitals in India by the end of 2019 as it...
      Sandoz receives approval in Europe for Erelzi to treat multiple inflammatory diseases

      Sandoz receives approval in Europe for Erelzi to treat multiple inflammatory diseases

      Ruby Khatun Khatun29 Jun 2017 9:58 AM IST
      Holzkirchen: Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced that the European Commission (EC) has approved...
      AstraZeneca cancer drug trial prompts investors to take options cover

      AstraZeneca cancer drug trial prompts investors to take options cover

      Ruby Khatun Khatun29 Jun 2017 9:58 AM IST
      London/New York: Investors in drugmaker AstraZeneca have taken defensive positions in the options market ahead of eagerly awaited results of a major...
      DoP accepts Sun Pharmas review petition on Fucibet cream 15 gm AI tube while rejecting Histac EVT 2’s AI strip

      DoP accepts Sun Pharma's review petition on Fucibet cream 15 gm AI tube while rejecting Histac EVT 2’s AI strip

      Ruby Khatun Khatun29 Jun 2017 9:57 AM IST
      The Department of Pharmaceuticals (DoP) has accepted Sun Pharmaceutical's review petition against price fixation of “Fucibet cream 15 gm AI tube” and...
      Before GST, NPPA releases ceiling price of 761 medicines, Check out details

      Before GST, NPPA releases ceiling price of 761 medicines, Check out details

      Ruby Khatun Khatun28 Jun 2017 12:40 PM IST
      New Delhi: Drug price regulator NPPA on Tuesday announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and...
      Natco Pharma receives final approval for generic Azacitidine for injection for USA market

      Natco Pharma receives final approval for generic Azacitidine for injection for USA market

      Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
      Hyderabad: Natco Pharma Limited announced that it has got the final approval of Abbreviated New Drug Application (ANDA) from the U.S. Food and Drug...
      Zydus Cadila gets final approval from USFDA for Hepatitis B tablets

      Zydus Cadila gets final approval from USFDA for Hepatitis B tablets

      Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
      AHMEDABAD: Cadila Healthcare Ltd (Zydus Cadila) said here on Tuesday that it has received the final approval from the USFDA to market Entecavir...
      Glenmark gets USFDA nod for generic anti-inflammatory drug

      Glenmark gets USFDA nod for generic anti-inflammatory drug

      Ruby Khatun Khatun28 Jun 2017 12:37 PM IST
      New Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for its generic version of anti-inflammatory drug...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok